PROMETHEUS BIOSCIENCES, INC. Proceeds from Stock Options Exercised
PROMETHEUS BIOSCIENCES, INC. reported Proceeds from Stock Options Exercised of $2.89 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-05-09
- PROMETHEUS BIOSCIENCES, INC. proceeds from stock options exercised for the quarter ending 2023-03-31 was $2.89M, a 728.94% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. proceeds from stock options exercised for the quarter ending 2022-12-31 was $3.32M, a 4158.97% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. proceeds from stock options exercised for the quarter ending 2022-09-30 was $1.24M, a 3651.52% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. proceeds from stock options exercised for the quarter ending 2022-06-30 was $72.00K, a 38.46% increase year-over-year.
- PROMETHEUS BIOSCIENCES, INC. proceeds from stock options exercised for fiscal 2022 was $4.98M, a 2001.69% increase from fiscal 2021.
- PROMETHEUS BIOSCIENCES, INC. proceeds from stock options exercised for fiscal 2021 was $237.00K, a 20.30% increase from fiscal 2020.
- PROMETHEUS BIOSCIENCES, INC. proceeds from stock options exercised for fiscal 2020 was $197.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2023-03-31 | $2.89M 10-Q · filed 2023-05-09 | $6.21M derived: sum of 2 quarters · filed 2023-05-09 | $7.45M derived: sum of 3 quarters · filed 2023-05-09 | $7.53M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $4.56M derived: sum of 2 quarters · filed 2023-02-28 | $4.63M derived: sum of 3 quarters · filed 2023-02-28 | $4.98M 10-K · filed 2023-02-28 |
| 2022-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.31M derived: sum of 2 quarters · filed 2022-11-09 | $1.66M 10-Q · filed 2022-11-09 | $1.74M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $421.00K 10-Q · filed 2022-08-11 | $499.00K derived: sum of 3 quarters · filed 2023-05-09 | $532.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | $349.00K 10-Q · filed 2023-05-09 | $427.00K derived: sum of 2 quarters · filed 2023-05-09 | $460.00K derived: sum of 3 quarters · filed 2023-05-09 | $512.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $111.00K derived: sum of 2 quarters · filed 2023-02-28 | $163.00K derived: sum of 3 quarters · filed 2023-02-28 | $237.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $85.00K derived: sum of 2 quarters · filed 2022-11-09 | $159.00K 10-Q · filed 2022-11-09 | $295.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $126.00K 10-Q · filed 2022-08-11 | $262.00K derived: sum of 3 quarters · filed 2023-02-28 | $266.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $74.00K 10-Q · filed 2022-05-12 | $210.00K derived: sum of 2 quarters · filed 2023-02-28 | $214.00K derived: sum of 3 quarters · filed 2023-02-28 | $262.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $140.00K derived: sum of 2 quarters · filed 2023-02-28 | $188.00K derived: sum of 3 quarters · filed 2023-02-28 | $197.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $52.00K derived: sum of 2 quarters · filed 2021-11-12 | $61.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $57.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $9.00K 10-Q · filed 2021-05-13 |